Çakır, Işın https://orcid.org/0000-0003-4293-7267
Hadley, Colleen K. https://orcid.org/0000-0002-9402-4462
Pan, Pauline Lining https://orcid.org/0000-0001-7961-6307
Bagchi, Rushita A. https://orcid.org/0000-0002-9075-0766
Ghamari-Langroudi, Masoud https://orcid.org/0000-0001-7222-8512
Porter, Danielle T. https://orcid.org/0000-0002-8042-3251
Wang, Qiuyu https://orcid.org/0000-0002-4333-986X
Litt, Michael J.
Jana, Somnath https://orcid.org/0000-0002-2830-9451
Hagen, Susan https://orcid.org/0000-0002-2073-3143
Lee, Pil
White, Andrew
Lin, Jiandie D. https://orcid.org/0000-0001-8069-5647
McKinsey, Timothy A. https://orcid.org/0000-0001-7778-4470
Cone, Roger D. https://orcid.org/0000-0003-3333-5651
Funding for this research was provided by:
Gouvernement du Canada | Canadian Institutes of Health Research (FRN-216927)
American Diabetes Association (7-21-JDF-032)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (P30-DK020572, DK118731, HL147558, R01DK070332, 1R01DK125830)
Klatskin-Sutker Discovery Fund at the University of Michigan, Life Sciences Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (HL116848, HL127240, HL147558)
American Heart Association (16SFRN31400013)
Article History
Received: 17 November 2020
Accepted: 7 December 2021
First Online: 17 January 2022
Competing interests
: T.A.M. is on the Scientific Advisory Board of Artemes Bio and Eikonizo Therapeutics, received funding from Italfarmaco for an unrelated project and has a subcontract from Eikonizo Therapeutics for an SBIR grant from the NIH (HL154959). I.C., A.W., P.L. and R.D.C. have filed a provisional patent application on non-hydroxymate HDAC6 blockers. Other authors declare no competing interests.